Saturday


0700 - 0730

Registration Desk Opens / Continental Breakfast

0730 - 0745

Welcome – Dr. Jagdish Butany, University Health Network, Toronto, ON

0745 - 0830

Quality Assurance in Immunohistochemistry
Dr. Kelly Dakin-Hache, QEII Health Sciences Centre Halifax, NS
(35 minute presentation, 10-minute Q&A)
At the end of this session, participants will be able to:

  • List variables that influence the results of immunohistochemical tests
  • Understand selection of appropriate normal tissue controls
  • Identify specific recommendations for use of positive and negative control tissues
  • Understand principles of test calibration and validation
  • Recognize importance of external quality control

0835 - 0935

 

Quality Assurance in Hematological Pathology
Dr. Ruth Frances Padmore, University of Ottawa, Ottawa, ON
 (45-minute presentation, 15 minutes Q&A)

At the end of this session, participants will be able to:

  • Describe quality in the hematology laboratory
  • List critical results – how are they handled
  • Recognize safety in the Laboratory
  • List laboratory errors (pre analytic, analytic and post analytic)
  • Describe instrument selection and validation

0935 - 1100

A Case Based Approach In Blood Transfusion
Dr. Irene Sadek , Dalhousie University, Halifax, NS
(70-minute presentation, 20 minutes Q&A)

At the end of this session, participants will be able to:

  • Describe complex cases in transfusion medicine
  • Identify clinical problems in replacement therapy
  • Describe technical aspects of blood banking
  • List issues in laboratory utilization in transfusion medicine

1035 - 1050

Refreshment Break

1100 - 1130

“Quality Assurance In Transfusion Medicine’’
Dr.  Irene Sadek, Dalhousie University, Halifax, NS
(20-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Explain the purpose and basic principles of a quality assurance program in transfusion medicine
  • List at least six (6) basis components of a transfusion medicie QA program
  • Describe at least three (3) strategies through which error identification can lead to quality improvement as part of a quality assurance program in transfusion medicine

1130 - 1245

Luncheon Seminar
Dr. Brian Cummings, Grand River Hospital, Kitchener-Waterloo, ON


1245 - 1345

“An Approach to Hemoglobinopathy Investigations”
Dr. Elaine Leung, University of Ottawa, Ottawa, ON
(45-minute presentation, 15-minute Q&A)

At the end of this session, participants will be able to:

  • Describe a practical approach to the investigation of the hemoglobinopathies
  • List the implications of the common haemoglobinopthies encountered in a clinical setting and how to advise clinicians regarding testing results
  • Demonstrate when to refer samples to a reference lab for further investigations
  • Describe the interpretation of hemoglobinopathy investigations throughout infancy and early childhood

1345 - 1445

“Selected Topics in Coagulation”
Dr. Jason Quinn - Dalhousie University, Halifax, NS
(50-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Identify key pre-analytical issues in coagulation testing  
  • Discuss the laboratory diagnosis of lupus anticoagulants
  • Discuss the laboratory monitoring of unfractionated heparin

1445 - 1500

Refreshment Break

1500 - 1600

Approach to Pediatric Hematopathology Pathology
Dr. Mohamed Abdelhaleem – Sick Kids Hospital, Toronto, ON
(50-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Describe bone marrow failure syndrome
  • Describe coagulation problems inpediatrics
  • recognize acute leukemia in Childhood

1600 - 1700

“Molecular diagnostics as applies to the current practice of Hematopathology and transition from residency”
Dr. Philip Berardi,
The Ottawa Hospital, Ottawa, ON
(50-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Understand some basic principles of molecular diagnostic testing as applied to complex malignant hematology.
  • Differentiate between clinically actionable mutations and predictive markers.
  • Critically appraise how monitoring by molecular methods in some hematolymphoid neoplasms can help predict long term survival.
  • Outline a general approach to laboratory management and quality assurance as it pertains to molecular diagnostics.
  • List key differences between an approved commercially available test and a validated laboratory developed test (LDT).

Sunday

0700 - 0730

Continental Breakfast - Early start!

0800 - 0830

"Approach to the Hematological Pathology Fellowship Examination"
Dr. Clinton Campbell, University of Toronto, Toronto, ON
(10-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Describe the overall format of the RCPSC exam in Hematological Pathology
  • Report on their additional knowledge of the evaluation processes that guide the HP examination
  • List techniques to maximize success in all components of the exam

0830 - 0930

“The Standardized Bone Marrow Examination: Pearls For Senior Residents In Transition To Practice’’
 Dr. Clinton Campbell, University of Toronto, Toronto, ON
(45-minute presentation, 15-minute Q&A)

At the end of this session, participants will be able to:

  • Review of standardized (ICSH, CAP, WHO) guidelines for bone marrow examination
  • Review of process and ICSH standardized guidelines for bone marrow IHC
  • Discuss key topics important for the RCPSC exam preparation and transition to practice
  • Brief overview of QC/QA pertaining to bone marrow

0930 - 1000

Review of Scanned Examination Slides
Dr. Ruth Padmore, The Ottawa Hospital, Ottawa, ON
(20-minute presentation, 10-minute Q&A)

1000 - 1015

Refreshment Break

1015 - 1130

“Application of Molecular Pathology in Solid and Liquid Tumours”
Dr. Christopher Howlett, University of Western Ontario, London, ON
(60-minute presentation, 15-minute Q&A)

At the end of this session, participants will be able to:

  • List molecular tests relevant to practice in Pathology
  • Explain the rationale for performing common molecular tests to improve accuracy of diagnosis in solid and liquid tumours
  • Discuss the role of particular molecular tests in predicting tumour response to therapy

1130 - 1230

Lunch

1230 - 1345

“Approach to Work-up and Diagnosis of Hematological Disorders”
Dr. Monalisa Sur, McMaster University, Hamilton, ON
(45-minute presentation, 15-minute Q&A)

At the end of this session, participants will be able to:

  • Handle various specimens in the lab with a clinical diagnosis of a lymphoproliferative disorder
  • Work up common reactive lymphadenopathies
  • Use a pattern based approach to create a differential diagnosis and distinguish various indolent and aggressive lymphomas
  • Describe the role (in diagnosis and prognosis) and judicious use of various ancillary tests such as immunohistochemistry, flow cytometry and molecular tests

1345 - 1430

“Practical Approach to Hematological Evaluation of Peripheral Blood”
Dr. Allam Shawwa,
Queen Elizabeth II Health Science Centre, Halifax, NS
(35-minute presentation, 10-minute Q&A)


At the end of this session, participants will be able to:
• Describe a practical approach to diagnosis of anemia
• Summarize a practical approach to diagnosis of acute leukemia, myeloproliferative and myelodysplastic disorders
• Apply a practical approach to lymphocytosis with update on small lymphocyte disorders

1430 - 1530

“Bone Marrow evaluation and Flow Cytometry”
Dr. Graham Quest,
Kingston Health Science Centre, Queen's University, ON
(45-minute presentation, 15-minute Q&A)


At the end of this session, participants will be able to:
• Follow the principles of integrated bone marrow diagnostics
• Compare normal vs. abnormal patterns of the main antigen combinations used in the flow cytometric diagnosis of bone marrow
• Summarize principles of flow cytometry diagnostics of hematological malignancies

1530  

Closing Remarks 

 


- last updated January 2019 -